Grifols SA
Pharmaceutical company · New York, United States · Nasdaq: GRFS
Grifols SA is a pharmaceutical company headquartered in New York, United States. Its shares trade on Nasdaq under the ticker GRFS.
Profile compiled from public records. Is this your company? Request a correction or update
Grifols at a glance
Typepharmaceutical company
HeadquartersNew York, United States
Stock listingNasdaq: GRFS
SEC industryPharmaceutical Preparations
SEC CIK1438569
Frequently asked questions about Grifols
Where is Grifols headquartered?
Grifols SA is headquartered in New York, United States.
What does Grifols do?
Grifols SA is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Grifols a public company?
Yes. Grifols SA trades on Nasdaq under the ticker GRFS.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences